Palak Trivedi

20PUBLICATIONS
116CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples cultural determinants of healthMajor global burdens of diseaseLiquid biopsiesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 30, 2026
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis.

Jörn M Schattenberg, Jesus M Banales, Gideon Hirschfield

|Mar 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid.

Sarah Dunn, Lysbeth Evans, Ciara Kennedy

|Dec 11, 2025
Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.

Usha Gungabissoon, Jake Hunnicutt, Eleanor J McDermott

|Dec 02, 2025
Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review.

Mohammed Nabil Quraishi, Maryam A Alahmad, Ala I Sharara

|Sep 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.

Nadir Abbas, Rachel Smith, Ellina Lytvyak

|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.

Cynthia Levy, Palak J Trivedi, Kris V Kowdley

Pageof 4

Frequent Collaborators

7 joint publications

Gideon M Hirschfield

4 joint publications

Christopher L Bowlus

4 joint publications

Marlyn Mayo

4 joint publications

Cynthia Levy